“Every strike brings me closer to the next home run.” ✍️ – Babe Ruth |
✅ U.S. stocks moved higher on Monday as signs of easing tensions in the Middle East lifted investor sentiment. President Trump said the U.S. would pause planned strikes on Iranian energy infrastructure for five days following constructive weekend talks. ✅ Sports betting stocks surged after U.S. senators proposed legislation to block prediction market platforms from offering sports-related contracts, easing competitive pressure on DraftKings and Flutter. ✅ Oil prices fell sharply after President Trump reported productive talks with Iran and suggested the Strait of Hormuz could reopen under joint U.S.-Iran control, easing supply concerns. ✅ Elon Musk announced Terafab, a $20–25 billion semiconductor project to produce cutting-edge chips for Tesla’s AI robotics and SpaceX’s space applications, aiming for unprecedented computing scale. ✅ Defense contractor AEVEX, backed by Madison Dearborn Partners, filed for a U.S. IPO on the NYSE under ticker “AVEX,” moving ahead despite regional geopolitical tensions. ✅ Gilead Sciences is nearing a $2 billion acquisition of Ouro Medicines to expand its biotech portfolio, with $1.5 billion upfront and $500 million contingent on clinical milestones. |
↗ Dow 46,208.47 + 1.38% ↗ Nasdaq 21,946.76 + 1.38% ↗ S&P 6,581.00 + 1.15% |
DraftKings and Flutter Soar as Senators Move to Restrict Sports Bets on Prediction Markets |
Image courtesy of Lorenzo Gordon |
Sports betting stocks rallied Monday following reports that U.S. lawmakers are preparing to crack down on prediction markets offering sports-related contracts. Shares of DraftKings and Flutter Entertainment surged after news that new legislation could limit competition from prediction market platforms. According to reporting from The Wall Street Journal, the proposed bill would prohibit these platforms from listing contracts tied to sporting events. The legislation is being introduced by Adam Schiff and John Curtis. The bill aims to restrict prediction market operators—such as Kalshi and Polymarket—from offering sports-related bets and casino-style products. Schiff argued that regulatory intervention is necessary, pointing to concerns about oversight. He criticized the Commodity Futures Trading Commission, saying it has effectively enabled the growth of these markets. Prediction markets have come under increasing scrutiny as they’ve rapidly expanded in recent years, particularly after the legalization of sports betting in the U.S. Many of these platforms now offer contracts tied to sports outcomes, putting them in direct competition with traditional sportsbooks. That competitive pressure appears to be easing—at least for now. DraftKings shares rose 4%, while Flutter climbed roughly 6% in early trading, reflecting investor optimism around potential regulatory limits on rival platforms. |
Oil Plunges as Trump Signals Iran Talks and Potential Reopening of Strait of Hormuz |
Image courtesy of oilandgasiq.com |
Oil prices tumbled sharply Monday morning after signs of easing tensions between the U.S. and Iran lifted hopes for improved global supply. Crude futures dropped more than 11% after Donald Trump said he held “productive” talks with Iran and would delay planned strikes on the country’s power infrastructure. The announcement marked a notable shift in tone following heightened tensions over the weekend. Trump also indicated that the Strait of Hormuz — a vital artery for global oil shipments — could reopen soon under a potential joint control arrangement between the U.S. and Iran, if negotiations progress. In response, oil markets pulled back significantly. U.S. benchmark West Texas Intermediate crude fell below $87 per barrel, while Brent crude dropped to around $98 after previously surging above $113. The president’s comments fueled optimism that a broader de-escalation could follow, particularly after he had warned just days earlier that Iran must fully reopen the strait within 48 hours or face military strikes. Despite the sharp decline, analysts remain cautious. Uncertainty persists around when oil flows through the Strait of Hormuz will fully resume, a key factor for global supply. Roughly a quarter of the world’s seaborne oil passes through the route, making any disruption highly consequential. Rebecca Babin of CIBC Private Wealth noted that while prices have fallen, further downside may be limited due to ongoing supply risks and the time required to restore normal shipping volumes. Each day of restricted flow represents a meaningful loss of supply, underscoring why markets remain sensitive to developments in the region despite the more optimistic headlines. | Elon Musk Unveils “Terafab”: A $25B Bet to Power Tesla and SpaceX’s AI Future |
Image courtesy of REUTERS/Kevin Lamarque/ |
Elon Musk has unveiled one of his most ambitious ideas yet: Terafab, a massive semiconductor project that could reshape the future of his companies, Tesla and SpaceX. Terafab is a joint venture between Tesla, SpaceX, and xAI that aims to bring every stage of chip production—design, manufacturing, memory, and packaging—under one roof. The facility will be built in Austin at Tesla’s Giga Texas campus and is expected to be even larger than the already विशाल complex. The project is expected to cost between $20 billion and $25 billion, and notably, these costs are not included in Tesla’s current capital expenditure plans. Its timing is also significant, as SpaceX is reportedly considering an IPO in the near future. Musk described Terafab as “the most epic chip-building effort in history,” driven by a critical need: existing chipmakers like TSMC and Samsung cannot produce chips fast enough to meet the demands of AI and robotics. “We either build Terafab or we don’t have the chips,” Musk said, underscoring the urgency. The facility will focus on two key chip types: Edge AI chips for Tesla’s self-driving systems, robotaxis, and Optimus humanoid robots Space-grade chips for satellites, orbital data centers, and AI workloads at SpaceX The biggest driver of demand is Tesla’s Optimus robot program. Analysts estimate that one factory alone could produce up to 10 million robots annually—requiring about 20 million chips, roughly six times Tesla’s current total chip demand. Looking further ahead, Tesla’s long-term vision of 100 million robots per year would require over 200 million chips, more than 50 times its current needs. Terafab will target cutting-edge 2-nanometer chip technology, placing it at the frontier of semiconductor manufacturing—an area where even industry leaders are still scaling up. Finally, Musk outlined an even bigger ambition: to produce over one terawatt of AI computing power annually, with much of it eventually deployed in space. While no firm timeline has been given, the project is expected to begin with prototyping and infrastructure testing, signaling the early stages of what could become one of the largest industrial efforts ever undertaken. |
Madison Dearborn-Backed Defense Contractor AEVEX Files for U.S. IPO on NYSE |
Image courtesy of Aevex.com |
Defense technology contractor AEVEX, backed by buyout firm Madison Dearborn Partners, filed Monday for an initial public offering in the United States. The IPO comes despite ongoing Middle East tensions, highlighting continued access to the U.S. equity markets. The Solana Beach, California-based company, along with some existing shareholders, plans to sell shares in the offering, which will be listed on the New York Stock Exchange under the ticker “AVEX.” Goldman Sachs, BofA Securities, and Jefferies are serving as lead underwriters for the IPO. |
Gilead Nears $2 Billion Buyout of Biotech Ouro Medicines |
Image courtesy of Gilead Sciences |
Gilead Sciences is reportedly close to acquiring Ouro Medicines for up to $2 billion, according to the Financial Times. The deal structure includes approximately $1.5 billion in upfront cash to Ouro’s private investors, with an additional $500 million contingent on achieving certain clinical trial milestones. The acquisition could be announced in the coming days, though timing and terms may still change. Both Gilead and Ouro Medicines have not immediately commented on the report. This move follows Gilead’s previous major acquisition of Arcellx for $7.8 billion, underscoring the company’s ongoing strategy of expanding its biotech and specialty treatment portfolio. Privately held Ouro is testing an antibody drug, gamgertamig, in early-stage studies to treat autoimmune conditions, including hemolytic anemia and Sjögren's disease, a muscle-weakening disorder. Gilead, best known for its HIV drugs, has been looking outside of its key areas for growth amid looming patent expiries and declining sales of its COVID-19 drug Veklury. The deal to acquire Ouro could be announced in the coming days, an FT report said, adding that the timing and terms could change. |
📉 ON THE MOVE AND NOTABLES 📈 |
✔️ Gains were widespread across sectors on Monday, with energy the only laggard, while growth sectors like technology and consumer discretionary were leading. ✔️ European markets also advanced, with the Euro Stoxx 50 up more than 1%. ✔️ Bond yields were slightly lower—the 10-year Treasury yield has dipped to 4.35%—and the U.S. dollar is weakening against a basket of currencies. ✔️ Global markets rallied on signs of de-escalation in the Middle East conflict. Over the weekend, tensions had escalated, with President Trump warning of potential strikes on Iranian energy and power assets if the Strait of Hormuz was not reopened. However, early Monday, he announced a five-day delay in any military action to allow for continued negotiations after what he described as productive discussions with Iran. ✔️ U.S. construction spending unexpectedly fell in January amid broad weakness in private projects, government data showed. The Commerce Department's Census Bureau said on Monday that construction spending dropped 0.3% after an upwardly revised 0.8% jump in December, which was the largest increase since April 2024. ✔️ Markets have struggled in March, as the conflict involving Iran pushed oil prices up more than 30%, dampening risk appetite. As of Friday’s close, the S&P 500 was down 5.4% for the month, while the Russell 2000 had fallen more than 7%. The S&P 500 Index notched its fourth consecutive weekly loss, slipping nearly 2% and falling below its November closing low. ✔️ Airline and cruise stocks jumped Monday after news that the U.S. will delay potential strikes on Iran’s power infrastructure. ✔️ Energy names moved in the opposite direction, with Exxon Mobil (XOM) and Chevron (CVX) edging lower. ✔️ Gold prices extended their decline, falling another 4% to below $4,400 per ounce after suffering their worst weekly drop in over four decades. The pullback followed last week’s hawkish Federal Reserve tone, which dampened expectations for rate cuts this year. ✔️ Silver dropped nearly 3% to one-month lows, while copper prices saw modest gains. ✔️ Mining stocks such as Freeport-McMoRan (FCX) and Newmont (NEM) also traded lower. ✔️ DraftKings (DKNG) surged after Citizens reaffirmed its outperform rating and $38 price target. ✔️ MongoDB (MDB) climbed following an upgrade from Mizuho, which cited an attractive setup after recent earnings. ✔️ Activist investor Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), the Wall Street Journal reported on Sunday. ✔️ Interest rate expectations have shifted sharply. According to the CME FedWatch Tool, the probability of a Fed rate cut this year has plunged from 95% a month ago to roughly 5% on Monday. ✔️ Bitcoin jumped 3% to trade near $71,000 on Monday as broader markets rose. |
💲What Else to Watch This Week💲 |
🟢 Tuesday (Mar. 24): New Home Sales. Earnings from AAR Corp. (AIR), Centessa Pharmaceuticals (CNTA), Concentrix Corp. (CNXC), Core & Main Inc. (CNM), GameStop Corp. (GME), Hesai Group (HSAI), KB Home (KBH), New Gold Inc. (NGD), Smithfield Foods Inc. (SFD), T1 Energy Inc. (TE), Worthington Enterprises Inc. (WOR). 🟢 Wednesday (Mar. 25): Current Account Balance, Durable Orders, EIA Crude Oil Inventories, Export Prices, Import Prices, Mortgage Applications Index. Earnings from Alumis Inc. (ALMS), Celcuity Inc. (CELC), Chewy Inc. (CHWY), Cintas Corp. (CTAS), H.B. Fuller Company (FUL), Jefferies Financial Group Inc. (JEF), JinkoSolar Holding Co. (JKS), Karman Holdings Inc. (KRMN), Ondas Inc. (ONDS), Paychex Inc. (PAYX), PDD Holdings Inc. (PDD), Winnebago Industries Inc. (WGO). 🟢 Thursday (Mar. 26): Continuing Claims, EIA Natural Gas Inventories, Initial Claims. Earnings from Argan Inc. (AGX), Bicara Therapeutics Inc. (BCAX), Commercial Metals Co. (CMC), Kodiak Sciences Inc. (KOD), Lumexa Imaging Holdings Inc. (LMRI), Pony AI (PONY), Seabridge Gold Inc. (SA), TMC the metals company Inc. (TMC). 🟢 Friday (Mar. 27): Advanced International Trade in Goods, Advanced Retail Inventories, Advanced Wholesale Inventories, GDP – 3rd Estimate, PCE Prices, Personal Income, Personal Spending, University of Michigan Consumer Sentiment – Final. Earnings from Autolus Therapeutics PLC (AUTL), Carnival Corp. (CCL), Humacyte Inc. (HUMA), Legence Corp. (LGN), SBC Metals Group Holdings (SBC). | Watch Our Latest Weekly Video On Youtube Or Spotify " Oil Surge Sparks Market Panic " |
|
|
Disclaimer: We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of Bullish Bear nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisers, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on Bullish Bear. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Bullish Bear makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Some of the content on this website contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which may be beyond a company’s control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. It is hereby noted that forward-looking statements contained herein may include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward-looking statements or announcements mentioned on this website or the websites contained within. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results. Generally, the information regarding a company profiled or discussed on this website is provided from public sources bullishbear.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained through our website or in communications originating from our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Bullish Bear has no obligation to update any of the information provided. Bullish Bear, its owners, officers, directors, contractors and employees are not responsible for errors and omissions. From time to time certain content on this website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled on this website may not have approved certain or any statements within the website. Bullish Bear encourages viewers to supplement the information obtained from this website with independent research and other professional advice. The content on this website is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Third Party Web Sites and Other Information This website may provide hyperlinks to third party websites or access to third party content. Bullish Bear, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Bullish Bear control, endorse, or guarantee any content found in such sites. Bullish Bear does not control, endorse, or guarantee content found in such sites. By accessing, viewing, or using the website or communications originating from the website, you agree that Bullish Bear, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Bullish Bear, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. Bullish Bear uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the United States Securities and Exchange Commission (SEC). The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or the Financial Industry Regulatory Authority (FINRA) at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm. |
|
|
Manage your preferences | Opt Out using TrueRemove™ Got this as a forward? Sign up to receive our future emails. View this email online. |
502 E Atlantic Ave 232 | Delray Beach, FL 33483 US |
|
|
This email was sent to punjabsvera@gmail.com. To continue receiving our emails, add us to your address book. |
|
|
|